Literature DB >> 8390935

Determination of the autonomously functioning volume of the thyroid.

D Emrich1, U Erlenmaier, M Pohl, H Luig.   

Abstract

The aim of this work was to determine the autonomously functioning volume in euthyroid and hyperthyroid goitres for prognostic and therapeutic purposes. To this end, various groups of patients were selected: individuals without evidence of thyroid disease, euthyroid patients with diffuse goitre of normal structure and function, euthyroid patients with evidence of autonomy and patients with hyperthyroidism due to autonomy. In all of them the thyroid uptake of technetium-99m was determined under exogenous suppression (TcUs) in the euthyroid state and under endogenous suppression (TcU) in the hyperthyroid state. It was demonstrated that: 1. In patients with unifocal autonomy the TcUs and TcU correlated linearly with the autonomous volume delineated and measured by sonography. 2. A nearly identical result was obtained if the mean autonomous volume in individuals without thyroid disease of 2.2 +/- 1.1 ml calculated by TcUs/TcU x total thyroid volume was used as a basis. 3. The critical autonomous volume, i.e. the volume at which hyperthyroidism will occur, was found to be 16 ml at a cumulated sensitivity and specificity of > 0.9. The method can be used to select patients for definitive treatment before hyperthyroidism occurs and to measure the autonomously functioning volume independent of its distribution within the thyroid for treatment with radioiodine. The method is easy to perform and is also an example of how a relative parameter of a function can be converted into an absolute parameter of a functioning volume.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390935     DOI: 10.1007/bf00208999

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  11 in total

Review 1.  Natural heterogeneity of thyroid cells: the basis for understanding thyroid function and nodular goiter growth.

Authors:  H Studer; H J Peter; H Gerber
Journal:  Endocr Rev       Date:  1989-05       Impact factor: 19.871

2.  Autonomy in euthyroid goitre: maladaptation to iodine deficiency.

Authors:  D Emrich; M Bähre
Journal:  Clin Endocrinol (Oxf)       Date:  1978-03       Impact factor: 3.478

3.  Autonomously functioning euthyroid multinodular goitre.

Authors:  J W Elte; A Haak; M Frölich; K S Wiarda; R K van Wermeskerken
Journal:  Neth J Med       Date:  1977       Impact factor: 1.422

4.  [Volumetric analysis of thyroid lobes by real-time ultrasound (author's transl)].

Authors:  J Brunn; U Block; G Ruf; I Bos; W P Kunze; P C Scriba
Journal:  Dtsch Med Wochenschr       Date:  1981-10-09       Impact factor: 0.628

5.  The autonomous functioning thyroid nodule in the evolution of nodular goiter.

Authors:  J M Miller; R C Horn; M A Block
Journal:  J Clin Endocrinol Metab       Date:  1967-09       Impact factor: 5.958

6.  Evolution of autonomy in idiopathic non-toxic goiter, evaluated by regional suppressibility of 99mTc-uptake and TSH response to TRH.

Authors:  H Dige-Petersen; O J Clemmensen; L Hummer
Journal:  Nuklearmedizin       Date:  1976-08       Impact factor: 1.379

7.  The different types of hyperthyroidism in Europe. Results of a prospective survey of 924 patients.

Authors:  D Reinwein; G Benker; M P König; A Pinchera; H Schatz; A Schleusener
Journal:  J Endocrinol Invest       Date:  1988-03       Impact factor: 4.256

8.  Morphologic and functional substrate of thyrotoxicosis caused by nodular goiters.

Authors:  H Studer; H R Hunziker; C Ruchti
Journal:  Am J Med       Date:  1978-08       Impact factor: 4.965

9.  Thyroid autonomy: sensitive detection in vivo and estimation of its functional relevance using quantified high-resolution scintigraphy.

Authors:  M Bähre; R Hilgers; C Lindemann; D Emrich
Journal:  Acta Endocrinol (Copenh)       Date:  1988-02

10.  Preclinical hyperthyroidism in multinodular goiter.

Authors:  E Gemsenjäger; J J Staub; J Girard; P Heitz
Journal:  J Clin Endocrinol Metab       Date:  1976-10       Impact factor: 5.958

View more
  6 in total

Review 1.  An update on diagnostic methods in the investigation of diseases of the thyroid.

Authors:  M J Reinhardt; E Moser
Journal:  Eur J Nucl Med       Date:  1996-05

2.  Dose selection for radioiodine therapy of borderline hyperthyroid patients according to thyroid uptake of 99mTc-pertechnetate: applicability to unifocal thyroid autonomy?

Authors:  Michael J Reinhardt; Kim Biermann; Michael Wissmeyer; Freimut D Juengling; Holger Brockmann; Dirk von Mallek; Samer Ezziddin; Alexius Y Joe; Thomas M Krause
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-16       Impact factor: 9.236

3.  Clinical dilemmas arising from the increased intake of iodine in the Spanish population and the recommendation for systematic prescription of potassium iodide in pregnant and lactating women (Consensus of the TDY Working Group of SEEN).

Authors:  F Soriguer; P Santiago; L Vila; J M Arena; E Delgado; F Díaz Cadórniga; S Donnay; M Fernández Soto; S González-Romero; P Martul; M Puig Domingo; S Ares; F Escobar del Rey; G Morreale de Escobar
Journal:  J Endocrinol Invest       Date:  2009-02       Impact factor: 4.256

Review 4.  Transfer from PET to SPET in cardiology, but the unit of reference is still the patient.

Authors:  O Schober; E Moser
Journal:  Eur J Nucl Med       Date:  1994-06

5.  Effect of iodinated contrast media on thyroid function in adults.

Authors:  Aart J van der Molen; Henrik S Thomsen; Sameh K Morcos
Journal:  Eur Radiol       Date:  2004-02-28       Impact factor: 5.315

6.  Negative correlation between therapeutic success in radioiodine therapy and TcTUs: are TcTUs-adapted dose concepts the only possible answer?

Authors:  Martin Gotthardt; Miriam Nowack; Martin P Béhé; Meike L Schipper; Anja Schlieck; Helmut Höffken; Thomas M Behr
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-06-25       Impact factor: 9.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.